NO963064L - Behandling av normotensive glaukoma med angiotensin-II-antagonister - Google Patents

Behandling av normotensive glaukoma med angiotensin-II-antagonister

Info

Publication number
NO963064L
NO963064L NO963064A NO963064A NO963064L NO 963064 L NO963064 L NO 963064L NO 963064 A NO963064 A NO 963064A NO 963064 A NO963064 A NO 963064A NO 963064 L NO963064 L NO 963064L
Authority
NO
Norway
Prior art keywords
treatment
angiotensin
antagonists
normotensive glaucoma
glaucoma
Prior art date
Application number
NO963064A
Other languages
English (en)
Other versions
NO963064D0 (no
Inventor
Alicia Huxley
Georg Mathis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO963064D0 publication Critical patent/NO963064D0/no
Publication of NO963064L publication Critical patent/NO963064L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Anvendelsen av en anglotensin-II-antagonist eller et farmasøytisk akseptabelt salt derav ved fremstilling av et farmasøytisk preparat for behandling av normal- trykk-glaukom og neurodegenerative prosesser.
NO963064A 1994-02-08 1996-07-23 Behandling av normotensive glaukoma med angiotensin-II-antagonister NO963064L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810071 1994-02-08
PCT/IB1995/000056 WO1995021609A1 (en) 1994-02-08 1995-01-26 Treatment of normotensive glaucoma with angiotensin ii antagonists

Publications (2)

Publication Number Publication Date
NO963064D0 NO963064D0 (no) 1996-07-23
NO963064L true NO963064L (no) 1996-07-23

Family

ID=8218203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963064A NO963064L (no) 1994-02-08 1996-07-23 Behandling av normotensive glaukoma med angiotensin-II-antagonister

Country Status (17)

Country Link
US (1) US5889020A (no)
EP (1) EP0743852B1 (no)
JP (1) JPH09508641A (no)
CN (1) CN1140409A (no)
AT (1) ATE300287T1 (no)
AU (1) AU1423795A (no)
CA (1) CA2181461A1 (no)
CY (1) CY2567B1 (no)
DE (1) DE69534339T2 (no)
DK (1) DK0743852T3 (no)
ES (1) ES2243933T3 (no)
FI (1) FI963083L (no)
IL (1) IL112520A0 (no)
MX (1) MX9603259A (no)
NO (1) NO963064L (no)
WO (1) WO1995021609A1 (no)
ZA (1) ZA95958B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125251C (en) * 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
AU684916B2 (en) * 1994-03-16 1998-01-08 Sankyo Company Limited Ocular tension depressant
JPH10167961A (ja) * 1996-12-11 1998-06-23 Santen Pharmaceut Co Ltd 緑内障治療剤
US6204281B1 (en) 1998-07-10 2001-03-20 Novartis Ag Method of treatment and pharmaceutical composition
KR20040078140A (ko) * 1998-07-10 2004-09-08 노파르티스 아게 발사르탄 및 칼슘 채널 차단제의 항고혈압 병용 제제
CA2371554C (en) * 1999-04-28 2009-06-09 Shizue Nakagawa Pharmaceutical composition comprising an angiotensin ii antagonist for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy
ES2242619T3 (es) * 1999-06-11 2005-11-16 Sankyo Company, Limited Composicion para disminuir la tension ocular para la administracion topica.
US6395728B2 (en) 1999-07-08 2002-05-28 Novartis Ag Method of treatment and pharmaceutical composition
WO2001030388A1 (en) * 1999-10-25 2001-05-03 Senju Pharmaceutical Co., Ltd. Tension-relieving agents for ciliary muscle
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
AU3408801A (en) 2000-02-18 2001-08-27 Takeda Chemical Industries Ltd Tnf-alpha inhibitors
WO2002045748A1 (en) * 2000-12-05 2002-06-13 Sankyo Company, Limited Ocular tension-lowering compositions for topical administration
EG24716A (en) 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas
WO2005118166A2 (en) 2004-06-04 2005-12-15 Teva Pharmaceutical Industries, Ltd. Pharmaceutical composition containing irbesartan
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
RU2420280C2 (ru) * 2005-04-21 2011-06-10 Сантен Фармасьютикал Ко., Лтд Терапевтическое средство против кератоконъюнктивального расстройства
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
NZ594302A (en) * 2008-12-29 2013-07-26 Trevena Inc Beta-arrestin effectors and compositions and methods of use thereof
RU2443416C2 (ru) * 2010-05-17 2012-02-27 Республиканское Унитарное производственное предприятие "Белмедпрепараты" Капли глазные
US9518086B2 (en) 2014-02-07 2016-12-13 Trevena, Inc. Crystalline and amorphous forms of a β-arrestin effector
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
CN105188250A (zh) * 2015-09-09 2015-12-23 上海联影医疗科技有限公司 靶组件以及具有该靶组件的直线加速器
CN105244434B (zh) * 2015-10-13 2017-10-10 北京科技大学 一种C掺杂ZnO热电材料的制备方法
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430709A3 (en) * 1989-12-01 1992-02-12 Glaxo Group Limited Benzthiophen derivatives
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma

Also Published As

Publication number Publication date
AU1423795A (en) 1995-08-29
ZA95958B (en) 1995-08-08
EP0743852B1 (en) 2005-07-27
DE69534339D1 (de) 2005-09-01
NO963064D0 (no) 1996-07-23
US5889020A (en) 1999-03-30
CA2181461A1 (en) 1995-08-17
DK0743852T3 (da) 2005-10-17
IL112520A0 (en) 1995-05-26
ATE300287T1 (de) 2005-08-15
JPH09508641A (ja) 1997-09-02
FI963083A0 (fi) 1996-08-05
MX9603259A (es) 1997-03-29
FI963083A7 (fi) 1996-08-07
DE69534339T2 (de) 2006-05-24
CN1140409A (zh) 1997-01-15
CY2567B1 (en) 2008-07-02
ES2243933T3 (es) 2005-12-01
WO1995021609A1 (en) 1995-08-17
EP0743852A1 (en) 1996-11-27
FI963083L (fi) 1996-08-07

Similar Documents

Publication Publication Date Title
DK1041990T3 (da) Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
FI963083L (fi) Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
NZ263084A (en) Dipeptide derivatives, treatment of immunomediated inflammatory disorders
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
FI954580L (fi) HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon
NO20005387L (no) 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer
MX9704684A (es) Derivados de glicina n-sustituidos, como inhibidores del factor xa.
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
HUP9902405A3 (en) Pharmaceutical compositions containing a serotonin antagonist for the treatment of the common cold or allergic rhinitis
IS4862A (is) Amínóísókínólín og amínóþíenópýridínafleiður og notkun þeirra sem bólgueyðandi efna
FI963883A7 (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
DK0804229T3 (da) Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl
DE69432595D1 (de) Antagonisten des angiotensin ii-rezeptors zur behandlung von chronischen entzündlichen erkrankungen
RU93047023A (ru) Производные имидазола-антагонисты ангиотензина-11, их получение и терапевтическое применение
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease
NO20013459L (no) Anvendelse av angiotensin II reseptorantagonister ved behandling av akutt myokardinfarkt
HU9701060D0 (en) Pharmaceutical composition for treating cognitive disturbs
FI911533A7 (fi) Bentsoksatsiini-johdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö sairauksien hoitamiseen tai ennalta ehkäisemiseksi
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
FI943989A7 (fi) Terapeuttisia tai ehkäiseviä aineita peroksilipidiin liittyviin sairauksiin
NO960308D0 (no) Terapeutisk aktive benzoksaziner og benzotioanoner